← Leaderboards
Yen Tun Wang
Curebiotech, Inc.
$1,999,932
Attributed
$1,999,932
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2019–20$2M$1.5M$1M$500K$0
'19
'20
Funding mix
By agency
NIH$1,999,932 · 1
By mechanism
R44$1,999,932 · 1
Top collaborators
No co-investigators on record.
Most similar at Curebiotech, Inc.
Same institution · by research overlap
- Yen T Wang$202,854
- Louis I Schure$125,438
Others in their field
Other Emerging Leaders on “Distant”
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$9,216,983
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$8,658,039
- Andrew Josef Ewald · Johns Hopkins University$6,197,797
- Kamila Naxerova · Massachusetts General Hospital$5,403,066
- Samuel F Bakhoum · Weill Medical Coll Of Cornell Univ$4,565,882
Research focus
DistantAcuteAgonistDimethyl SulfoxideAntigensAnti-Pd-1Anti-Pd1 TherapyAntiviral ResponseAntigen PresentationBloodBusinessesCancer CellCancer PatientCanis FamiliarisCd8b1 GeneCessation Of LifeClinical OncologyClinical TrialsBaseCutaneous T-Cell LymphomaCytokineDendritic CellsDesignDose